MCTC Holdings Inc. (MCTC) Launches Groundbreaking Study on THC-V and Weight Loss Amidst Wave of Industry Growth

• The company has filed six patents on hemp extract technologies and delivery systems pending approval with USPTO
• MCTC uses strategic agreements, acquisitions, and intellectual property to achieve multiple growing verticals within global cannabis industry
• Hemp industry continues to experience sustainable growth in wake of 2018 industrial hemp legalization

MCTC Holdings Inc. (OTC: MCTC), a cannabinoid science innovator doing business as Cannabis Global, announced the completion of its R&D phase for its Hemp You Can Feel(TM) line of sweeteners and coffee creamers. The product line is comprised of two organic natural sweeteners, two low-calorie sweeteners, and three powdered non-dairy creamers. Each product will feature the company’s patent pending Hemp You Can Feel(TM) technology, based on all-natural hemp infusions (http://cnw.fm/5aliW).

According to MCTC Holdings CEO Arman Tabatabaei, products in the lineup also utilize 100 percent natural infusions of hemp. “With our technology, chemical surfactants, emulsifiers and processing agents are not needed,” Tabatabaei said. “Consumers can now simply and easily add these sweeteners and non-dairy creamers to beverages for easy flavorings.”

The launch of the sweetener and non-dairy creamer line came shortly after the company released its Hemp You Can Feel(TM) CBD and hemp extract coffee line in single-serving compostable pods and packaging (http://ibn.fm/lnPD4). According to Tabatabaei, this is a unique product line based on what MCTC believes to be the most bioavailable infusion technologies in the marketplace. Hemp You Can Feel(TM) Coffee is based on a unique patented and patent pending set of dual infusion technologies. The dual infusion process differs markedly from the practices of most hemp coffee brands, which just spray the coffee with extract. This process could significantly increase the amount of hemp extracts usable by the body.

Each single serving pod delivers approximately 30 milligrams of CBD and additional hemp extracts via a unique water-soluble, all-natural formulation. Additionally, the products used are organic and of superior quality. The company monitors the entire production process as green coffee beans are imported from South America, roasted, and ground on site.

MCTC recently filed patents on six different technologies on cannabinoids, hemp extracts and delivery systems, currently pending approval with the USPTO. The company is focused on high-growth and high-margin sub-sectors of the cannabis and hemp industry, including the use of minor cannabinoid (THC-V) as an appetite suppressant or weight loss tool. In this regard, MCTC has already completed Phase One of its Project Varin, a program designed to develop delivery systems and uses for THC-V, and is now moving into the second phase of research (http://ibn.fm/v04Ad).

The company achieved its main goal in Phase One, which was to produce highly concentrated THC-V nanoscale fibers, as well as the secondary one, examining pH sensitivity issues. Company researchers are now organizing a groundbreaking study: the first animal study in the industry to determine if consumption of THC-V leads to weight loss and/or appetite suppression.

Tabatabaei commented that to date, no studies validating the potential for THC-V as an aid to appetite suppression and weight loss exist. “We plan to use several internally developed delivery systems in a diet-induced obesity model (DIO) utilizing C57 Black 6 male mice. These delivery systems will include our internally developed patent pending nanoparticle and fiber technologies, and our patent pending 100% natural infusion technologies originally developed for CBD, which will now be applied to THC-V.”

MCTC’s latest developments come against the background of a massive U.S. hemp industry growth following the 2018 Farm Bill that legalized the cultivation of industrial hemp. The sector was worth millions just a year after federal legalization, augmented by the demand for hemp-derived CBD. According to research from BDS Analytics and Arcview Market Research, the U.S. CBD market is expected to reach $20 billion in sales by 2024 (http://ibn.fm/pUMyi). Meanwhile, the global industrial hemp market is poised to grow exponentially as well – from $4.6 billion in 2019 to $26.6 billion by 2025, recording a CAGR of 34%, as indicated by a Research and Markets report (http://ibn.fm/6Vs3H).

For more information, visit the company’s website at www.CannabisGlobalInc.com

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://ibn.fm/MCTC

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php